Scinopharm Taiwan Limited (1789):企業概要、財務及び戦略的SWOT分析

◆英語タイトル:Scinopharm Taiwan Limited (1789) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH183543FSA
◆発行会社(調査会社):GlobalData
◆発行日:2015年1月9日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:台湾
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD300 ⇒換算¥32,100見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD600 ⇒換算¥64,200見積依頼/購入/質問フォーム
Global Site License(複数国内共有可)USD900 ⇒換算¥96,300見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary

ScinoPharm Taiwan, Ltd. (ScinoPharm) is a pharmaceutical company. The company develops and manufactures APIs and intermediates for pharmaceutical industry. Its products include atazanavir sulfate, benazepril hydrochloride, docetaxel anhydrous, flavoxate hydrochloride, galantamine hydrobromide, granisetron hydrochloride, tamsulosin hydrochloride, ondansetron hydrochloride, irinotecan hydrochloride, irinotecan hydrochloride, fosaprepitant dimeglumine, lapatinib ditosylate and dantrolene sodium. ScinoPharm offers peptide synthesis technologies. The company’s services include analytical and regulatory services, chemical process development, exploratory process research and consulting services. It markets products through a network of distributors in Germany, Scandinavia, France and the US. The company has manufacturing facilities in China and Taiwan. ScinoPharm is headquartered in Shan Hua, Taiwan.

Scinopharm Taiwan Limited Key Recent Developments

Dec 12, 2013: ScinoPharm Completes Changshu, China Plant

This comprehensive SWOT profile of Scinopharm Taiwan Limited provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Scinopharm Taiwan Limited including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Scinopharm Taiwan Limited – Key Information
Scinopharm Taiwan Limited – Overview
Scinopharm Taiwan Limited – Key Employees
Scinopharm Taiwan Limited – Key Employee Biographies
Scinopharm Taiwan Limited – Key Operational Heads
Scinopharm Taiwan Limited – Major Products and Services
Scinopharm Taiwan Limited – History
Scinopharm Taiwan Limited – Company Statement
Scinopharm Taiwan Limited – Locations And Subsidiaries
Scinopharm Taiwan Limited – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Scinopharm Taiwan Limited – Business Description
Scinopharm Taiwan Limited – Corporate Strategy
Scinopharm Taiwan Limited – SWOT Analysis
SWOT Analysis – Overview
Scinopharm Taiwan Limited – Strengths
Scinopharm Taiwan Limited – Weaknesses
Scinopharm Taiwan Limited – Opportunities
Scinopharm Taiwan Limited – Threats
Scinopharm Taiwan Limited – Key Competitors

Section 3 – Company Financial Performance Charts

Scinopharm Taiwan Limited – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Scinopharm Taiwan Limited, Key Information
Scinopharm Taiwan Limited, Key Ratios
Scinopharm Taiwan Limited, Share Data
Scinopharm Taiwan Limited, Major Products and Services
Scinopharm Taiwan Limited, History
Scinopharm Taiwan Limited, Key Employees
Scinopharm Taiwan Limited, Key Employee Biographies
Scinopharm Taiwan Limited, Key Operational Heads
Scinopharm Taiwan Limited, Other Locations
Scinopharm Taiwan Limited, Subsidiaries
Scinopharm Taiwan Limited, Key Manufacturing facilities
Scinopharm Taiwan Limited, Key Competitors
Scinopharm Taiwan Limited, SWOT Analysis
Scinopharm Taiwan Limited, Ratios based on current share price
Scinopharm Taiwan Limited, Annual Ratios
Scinopharm Taiwan Limited, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Scinopharm Taiwan Limited, Performance Chart
Scinopharm Taiwan Limited, Ratio Charts

★海外企業調査レポート[Scinopharm Taiwan Limited (1789):企業概要、財務及び戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • YOOX S.p.A. (Inactive):企業の戦略・SWOT・財務分析
    SummaryYOOX S.p.A. (Inactive) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key …
  • PetroMaroc Corporation Plc (PMA):企業の財務及び戦略的SWOT分析
    Summary Petromaroc Corporation Plc (Petromaroc) is an oil and gas exploration company that evaluates, acquires, explores and develops oil and gas properties in Morocco. The company was formerly known as Longreach Oil and Gas Ltd. It holds various offshore and onshore exploration licences such as Tar …
  • Nice-Pak Products, Inc.:企業の戦略・SWOT・財務分析
    SummaryNice-Pak Products, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key …
  • Hybrigenics SA (ALHYG):製薬・医療:M&Aディール及び事業提携情報
    Summary Hybrigenics SA (Hybrigenics) is a biopharmaceutical company that develops new targets and therapies against proliferative and non-cancerous diseases. Its lead product candidate Inecalcitol, is a vitamin D receptor agonist being assessed for various cancer indications including prostate cance …
  • Manila Bulletin Publishing Corp.の企業概要及び財務/SWOT分析
    Manila Bulletin Publishing Corp. Fundamental Company Report provides a complete overview of the company’s affairs. The report includes financial and SWOT information, industry analysis, opinions, estimates, Manila Bulletin Publishing Corp. annual and quarterly forecasts made by stock market experts. …
  • Sega Sammy Holdings Inc (6460):企業の財務・戦略的SWOT分析
    Sega Sammy Holdings Inc (6460) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Quest Diagnostics Incorporated (DGX):企業の財務及び戦略的SWOT分析
    Quest Diagnostics Incorporated (DGX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Banyan Tree Holdings Ltd:戦略・SWOT・企業財務分析
    Banyan Tree Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Banyan Tree Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Icelandair Group:企業概要・SWOT・財務分析
    Summary Canadean's "Icelandair Group : Travel and Tourism - Company Profile, SWOT and Financial Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business description, …
  • Allan Myers Inc:企業の戦略・SWOT・財務情報
    Allan Myers Inc - Strategy, SWOT and Corporate Finance Report Summary Allan Myers Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Banco Popular Espanol, S.A. (POP):企業概要およびSWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Banco Popular Espanol, S.A." The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strict …
  • Lifetime Brands, Inc. (formerly Lifetime Hoan Corp):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Lifetime Brands, Inc. (formerly …
  • Shanghai SECCO Petrochemical Co Ltd:企業の戦略的SWOT分析
    Shanghai SECCO Petrochemical Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Canadian Imperial Bank of Commerce:企業のM&A・提携・投資分析
    Canadian Imperial Bank of Commerce - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Canadian Imperial Bank of Commerce Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on m …
  • Prestige Brands Holdings, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Prestige Brands Holdings, Inc. …
  • MedMira Inc. (MIR):(医療機器分野)企業M&A及び提携動向
    Summary MedMira Inc. (MedMira) is a diagnostic company. The company develops, manufactures and commercializes rapid diagnostic tests to control and prevent the spread of HIV. Its products include reveal HIV, H. Pylori, Syphilis, multiplo, and Miriad RVF toolkit. MedMira’s Rapid Vertical Flow Technol …
  • Cybernet Systems Corporation:企業の戦略・SWOT・財務分析
    SummaryCybernet Systems Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company …
  • Cubic Energy, Inc. (CBNR)(石油・ガス分野):企業M&A動向
    Summary Cubic Energy, Inc. (Cubic) is an upstream energy company. The company explores, develops, and produces activities for crude oil and natural gas. It concentrates on the integration of earth sciences, engineering, and financial management in oil and gas exploration and development. Cubic’s pro …
  • Halla Holdings Corp. (formerly Mando Corporation):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Halla Holdings Corp. (formerly …
  • The First International Bank of Israel Ltd. (FTIN1):企業概要・SWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "The First International Bank of Israel Ltd." The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆